Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CYCN: Cyclerion Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
CYCN
The Story
CYCN
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+3.7% / yr
Operating margin
-337.4%
ROIC
-99.0%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
1.80×
Cyclerion Therapeutics, Inc.
CYCN
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Cyclerion Therapeutics, Inc.
CYCN
NASDAQ
·
USD
·
Closed
$3.44
−1.71%
$3.44
−$0.06 (1.71%)
52W Range
32th
pctl
Volume
0.41×
avg
Mkt Cap
14.90M
USD
P/E
-2.4
TTM
Div Yield
–
ann
52W Range
32th
pctl
Volume
0.41×
avg
Market Cap
14.90M
USD
P/E Ratio
-2.4
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings